
The North and Nigerian media: Each bird sings the song of its flickASML FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ASML Holding N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ASML
Rico Carty, who won the 1970 NL batting title when he hit a major league-best .366 for the Atlanta Braves, has died. He was 85. Major League Baseball , the players' association and the Braves paid tribute to Carty on social media on Sunday. No further details on Carty's death were provided.
Pro Picks is a weekly column where AP Pro Football Writer Rob Maaddi shares his picks for upcoming games. For all previous Pro Picks, head here . Playoff berths, draft positioning and more are up for grabs in Week 17. There’s going to be plenty of football on television this holiday week with the NFL playing games on five out of six days, starting with a doubleheader on Christmas Day featuring four of the AFC’s top five teams. Patrick Mahomes and the two-time defending Super Bowl champion Kansas City Chiefs visit Russell Wilson and the Pittsburgh Steelers on Wednesday. Then, two-time NFL MVP Lamar Jackson and the Baltimore Ravens take on C.J. Stroud and the Houston Texans. The Bears host the Seahawks on Thursday night and there are three games on Saturday, making Sunday’s schedule light at nine games. The Lions-49ers wrap up the weekend on Monday night. Pro Picks goes for another winning week. Line: Chargers minus 4 The Chargers would clinch a wild-card spot with a victory over the Patriots, who battled hard against the Bills. Los Angeles is 9-2 against the spread as favorites. Justin Herbert is 9-0 ATS in the Eastern time zone in his career. The Patriots have lost eight straight home games in December. BEST BET: CHARGERS: 23-16 Line: Bengals minus 3 Joe Burrow and the Bengals have to win to keep their slim playoff hopes alive. They’re favorites for the 12th time this season despite a losing record. The Broncos would clinch a wild-card berth with a win. They’re 11-4 ATS. UPSET SPECIAL: BRONCOS: 23-22 Line: Chiefs minus 3 The Chiefs can set a franchise record for wins in the regular season and wrap up the No. 1 seed along with home-field advantage throughout the AFC playoffs as they continue their quest for a third straight Super Bowl title. Kansas City got another playmaker when wide receiver Marquise Brown made his season debut. Mahomes is 3-0 with 14 touchdowns and no interceptions in his career vs. Pittsburgh. The scuffling Steelers are trying to snap a two-game losing streak after missing an opportunity to clinch the AFC North. Wide receiver George Pickens should return from a hamstring injury and he’ll open up the passing game for Wilson and the offense. CHIEFS: 24-20 Line: Ravens minus 5 1/2 The Ravens have won five in a row over the Texans, including 34-10 in a divisional playoff game last season. Baltimore can move into first place in the AFC North with a win and loss by Pittsburgh. But Jackson and Derrick Henry face a tough challenge against Houston’s defense. Stroud and the Texans are reeling after losing receiver Tank Dell to a devastating knee injury. RAVENS: 23-19 Line: Seahawks minus 3 1/2 The Seahawks have to win to maintain slim playoff hopes. The Bears have lost nine straight. Geno Smith and Jaxon Smith-Njigba should have a big day against Chicago’s pass defense. SEAHAWKS: 26-20 Line: Rams minus 6 A four-game winning streak has the Rams on the verge of securing the NFC West. Los Angeles aims to avenge a lopsided loss to Arizona in Week 2. The Cardinals were eliminated from the playoffs and are reduced to playing spoiler. With Kyren Williams leading the rushing attack, the Rams don’t have to rely on Matthew Stafford’s passing as much. RAMS: 26-16 Line: Bills minus 10 The Bills will know going in if they have a shot at the AFC’s No. 1 seed. If the Chiefs beat the Steelers and lock it up, Buffalo’s main priority will be keeping Josh Allen and everyone healthy. Still, they can rest in Week 18. After a subpar effort against the Patriots, the Bills can’t take Aaron Rodgers and the Jets lightly. BILLS: 27-16 Line: Raiders minus 1 The Raiders already hurt their draft positioning by beating the Jaguars last week. Another win could further knock them down and negatively impact their quest for a franchise quarterback. But coach Antonio Pierce wants to win and the players don’t care about draft slots. The Saints can’t get to the end of the season fast enough. RAIDERS: 20-16 Line: Buccaneers minus 8 The Panthers have embraced the spoiler role and coach Dave Canales will try to derail his former team’s playoff hopes. Bryce Young keeps improving and Chuba Hubbard is having a career year. The Buccaneers would’ve lost to Carolina last month if Hubbard didn’t fumble in overtime. Baker Mayfield and a turnover-prone offense have to overcome a depleted defense that couldn’t stop Cooper Rush and the Cowboys. BUCCANEERS: 26-20 Line: Jaguars minus 1 The winner of this one really loses because it’ll be costly in the race for draft positioning. TITANS: 19-17 Line: Colts minus 8 The Giants have come too far to lose the No. 1 pick in the draft. The Colts are clinging to slim playoff hopes. Jonathan Taylor and Anthony Richardson combined for 308 yards and four TDs against the Titans. They could have similar results against New York. COLTS: 27-16 Line: Eagles minus 9 1/2 The Cowboys are left to play for a winning record after being eliminated from the playoff race. The Eagles still need a win to secure the NFC East, but are almost locked into the No. 2 seed. If Jalen Hurts can’t play because of a concussion, Dallas has a shot against Kenny Pickett. Saquon Barkley is 268 yards away from breaking Eric Dickerson’s single-season rushing record. He could have a big day facing the fifth-worst run defense in the NFL. EAGLES: 24-17 Line: Vikings minus 1 The Vikings are two wins away from the NFC’s No. 1 seed with Sam Darnold. Let that sink in. But those won’t be easy victories. Minnesota has to beat Green Bay and then Detroit on the road to win the NFC North and get home-field advantage throughout the playoffs. The Vikings defeated the Packers 31-29 in Green Bay in September. They’re getting the Packers on short rest off a Monday night rout. The Vikings have been overlooked and underrated. This is a statement game. VIKINGS: 27-22 Line: Dolphins minus 6 1/2 Tua Tagovailoa and the Dolphins still have slim playoff changes and get an opportunity to win a game in cold weather. A loss helps the Browns hold onto a top-five pick in the draft. DOLPHINS: 25-16 Line: Commanders minus 4 The Falcons regained control of their NFC South hopes when the Buccaneers lost. Now, they have a tough test against the Commanders with Michael Penix Jr. making his second start facing off against Jayden Daniels in another matchup between rookie QBs. Daniels beat Caleb Williams and the Bears earlier this season on a Hail Mary. Washington clinches a playoff berth with a win or a loss by Tampa Bay. COMMANDERS: 24-23 Line: Lions minus 4 The Lions aim to avenge their loss in the NFC championship game, though this matchup lost its luster because the 49ers are eliminated from the playoff race. Detroit clinches the NFC’s No. 1 seed with a win if the Packers beat the Vikings. If Minnesota beats Green Bay, the Lions have to beat the Vikings in Week 18 to win the division and secure the top seed so the result against San Francisco won’t matter. In that case, Dan Campbell could choose to rest some of his starters in preparation for a winner-take-all regular-season finale. LIONS: 26-23 Last week: 12-4. Against spread: 8-7-1 Overall: Straight up: 168-72. Against spread: 131-105-4. Prime-time: Straight up: 39-14. Against spread: 29-23-1. Best Bet: Straight up: 9-7. Against spread: 8-8. Upset Special: Straight up: 9-7. Against spread: 9-7. AP NFL: https://apnews.com/hub/nflTarget Has the Coolest Black Friday Toy Deal for GamersMutual of America Capital Management LLC reduced its holdings in shares of Credo Technology Group Holding Ltd ( NASDAQ:CRDO – Free Report ) by 0.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 102,209 shares of the company’s stock after selling 958 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Credo Technology Group were worth $3,148,000 as of its most recent SEC filing. Other hedge funds have also made changes to their positions in the company. Swedbank AB boosted its holdings in Credo Technology Group by 873.9% in the third quarter. Swedbank AB now owns 3,300,314 shares of the company’s stock valued at $101,650,000 after purchasing an additional 2,961,454 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Credo Technology Group by 7.7% in the 1st quarter. Vanguard Group Inc. now owns 15,063,781 shares of the company’s stock valued at $319,202,000 after buying an additional 1,072,301 shares in the last quarter. Principal Financial Group Inc. grew its position in shares of Credo Technology Group by 22.7% in the 3rd quarter. Principal Financial Group Inc. now owns 1,993,968 shares of the company’s stock valued at $61,415,000 after buying an additional 368,518 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in Credo Technology Group by 27.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,697,723 shares of the company’s stock worth $54,225,000 after acquiring an additional 362,634 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Credo Technology Group by 62.7% in the second quarter. Bank of New York Mellon Corp now owns 654,773 shares of the company’s stock valued at $20,913,000 after acquiring an additional 252,349 shares during the last quarter. Hedge funds and other institutional investors own 80.46% of the company’s stock. Analyst Upgrades and Downgrades Several equities analysts have issued reports on the company. Barclays raised their price objective on Credo Technology Group from $30.00 to $32.00 and gave the stock an “overweight” rating in a report on Thursday, September 5th. Craig Hallum lifted their price target on Credo Technology Group from $30.00 to $38.00 and gave the stock a “buy” rating in a research report on Thursday, September 5th. Mizuho boosted their price objective on Credo Technology Group from $35.00 to $41.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. TD Cowen upgraded shares of Credo Technology Group to a “strong-buy” rating in a research report on Monday, September 16th. Finally, Roth Mkm upped their price target on shares of Credo Technology Group from $35.00 to $45.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $36.56. Insider Transactions at Credo Technology Group In other news, CEO William Joseph Brennan sold 143,880 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $25.75, for a total transaction of $3,704,910.00. Following the transaction, the chief executive officer now directly owns 2,529,738 shares of the company’s stock, valued at $65,140,753.50. This represents a 5.38 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink . Also, COO Yat Tung Lam sold 10,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $27.69, for a total transaction of $276,900.00. Following the completion of the sale, the chief operating officer now owns 2,885,840 shares of the company’s stock, valued at $79,908,909.60. This trade represents a 0.35 % decrease in their position. The disclosure for this sale can be found here . In the last three months, insiders sold 1,324,817 shares of company stock valued at $43,552,936. Corporate insiders own 16.04% of the company’s stock. Credo Technology Group Price Performance NASDAQ:CRDO opened at $45.84 on Friday. The firm has a market cap of $7.61 billion, a price-to-earnings ratio of -288.63 and a beta of 2.19. The firm’s fifty day moving average price is $37.02 and its 200 day moving average price is $30.75. Credo Technology Group Holding Ltd has a 1-year low of $16.82 and a 1-year high of $48.94. Credo Technology Group ( NASDAQ:CRDO – Get Free Report ) last issued its quarterly earnings results on Wednesday, September 4th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.03). The firm had revenue of $59.71 million for the quarter, compared to analyst estimates of $59.50 million. Credo Technology Group had a negative return on equity of 3.74% and a negative net margin of 12.05%. As a group, analysts expect that Credo Technology Group Holding Ltd will post -0.02 earnings per share for the current fiscal year. Credo Technology Group Company Profile ( Free Report ) Credo Technology Group Holding Ltd provides various high-speed connectivity Credo Technology Group Holding Ltd provides various high-speed connectivity solutions for optical and electrical Ethernet applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally. Its products include HiWire active electrical cables, optical digital signal processors, low-power line card PHY, serializer/deserializer (SerDes) chiplets, and SerDes IP, as well as integrated circuits, active electrical cables. Further Reading Want to see what other hedge funds are holding CRDO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Credo Technology Group Holding Ltd ( NASDAQ:CRDO – Free Report ). Receive News & Ratings for Credo Technology Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Credo Technology Group and related companies with MarketBeat.com's FREE daily email newsletter .
Ohio State AD: Ryan Day ‘absolutely’ back in 2025
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.Target Has the Coolest Black Friday Toy Deal for Gamers
Ducommun: More Upside On Boeing And Airbus Ramp UpTrump vows to pursue executions after Biden commutes most of federal death row
10 events that made the headlines in SingaporeTarget just recently kicked off its official Target Black Friday Sale , and one deal you might have missed is this really awesome MEGA Microsoft Xbox 360 Collector Building Set . It's normally $150 but there's a 50% discount for Black Friday that drops it to only $74.99. MEGA is similar to LEGO, but the brand (which is owned by Mattel) creates sets for IPs that don't have a relationship with the other famous big block company. Some past and present examples include Pokemon, Star Trek, Halo, and, in this case, Microsoft Xbox. This would make an incredible gift idea for any gaming fan who loves working on complex building block kits like LEGO. The MEGA Microsoft Xbox 360 Collector Building Set is a buildable 3:4 scale replica of the Xbox 360 console with a brick count total of 1,342 pieces (5.5 cents per brick). The details in this build are, frankly, incredible, and include interactive elements, lighting effects, and the coolest accessories. Here's a rundown of the biggest highlights: The Xbox console exterior is well represented with details like a removable hard drive, ventilation holes in the rear, text in the right places, and lighting effects. Unfortunately, there's no option to swap in a red ring of death. The Xbox console internals are just as faithfully reproduced as the exterior. There's a tray to pop in the supplied Xbox game disc (we'll get to this later), the motherboard, various heatsinks and doodads all connected by wires, and even a fancy little Cortana chip. It's also easy to get into the console (just press a little green button). The set includes an authentic looking mini Halo 3 game disc complete with a detailed Halo game box that looks just like the real thing. That's not even the best part. You can place the Halo disc into the console's internal disc tray and it will light up the Cortana chip inside. How cool is that!?! The Xbox controller has a removable battery pack. When you slide in the battery pack, the controller's guide button lights up. That's because the light brick is installed in the battery itself. So why the big price drop? According to the user reviews, the fit and finish of the bricks is not as good as LEGO sets, so the build process won't go as smoothly (you might even need to whip out the Kragle). But once you're done, I'm sure you'll appreciate the incredible amount of authentic features that the designers put into this set. If you want to keep your building block collection strictly LEGO, check out our guide to all of the best LEGO Black Friday deals available right now. There are plenty of big discounts on sets for all ages from multiple retailers, including LEGO Shop, Amazon, Best Buy, and of course, Target. We’re in the home stretch: Black Friday falls on November 29 this year. All month long, retailers have been rolling out sales, ramping up to massive discounts on Black Friday and through the weekend into Cyber Monday. There are already some fantastic deals available on PS5 consoles and controllers , video games for all platforms, AirPods Pro , and tons more. Eric Song is the IGN commerce manager in charge of finding the best gaming and tech deals every day. When Eric isn't hunting for deals for other people at work, he's hunting for deals for himself during his free time.
HENDERSON, Nev. (AP) — Aidan O'Connell will start at quarterback when the Las Vegas Raiders visit the Kansas City Chiefs on Friday. Raiders coach Antonio Pierce made the announcement Wednesday, saying O'Connell had progressed well after breaking his right thumb on Oct. 20 in a game against the Los Angeles Rams. Gardner Minshew broke his left collarbone on Sunday in a game against the Denver Broncos and is out for the season. The Raiders could have gone with Desmond Ridder to replace Minshew. AP NFL: https://apnews.com/hub/NFL
Melody Heald is a culture writer. Her work can be found in Glitter Magazine, BUST Magazine, and more.